Inventor · disambiguated record
Evis Sala
Also filed as: SALA EVIS
3 granted patents·1 pending application·1 citations·filing 2015–2024
55Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER4
Top patents by PatentIndex Score
4 records- 0182US2025144086A1Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0276US12036212B2Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 0374US10413533B2Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Sep 17, 2019·1 cites·10 claims
- 0470US11285137B2Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Mar 29, 2022·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Evis Sala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →